Medexus Pharmaceuticals Inc at Openexchange Share Series (Virtual) Transcript
Good morning. Welcome to the SHARE Series Monday Management Update. I am Frank Candido, and I have the pleasure of speaking with Kenneth d'Entremont, CEO at Medexus; and Marcel Konrad, CFO at Medexus. (Operator Instructions) Ken?
' -
Thank you, Frank. Thank you for the opportunity to present Medexus here to you this morning. Medexus is traded on the TSX under the ticker symbol, MDP, and on the OTCQX, under the ticker symbol MEDXF.
I will just go to the next slide, please.
This is our forward-looking statement. Our forward-looking statement can be found on our website at medexus.com, along with lots of other useful information for investors.
Let's go to the next slide, and we'll start to describe the company.
In a nutshell, Medexus is a commercially focused pharma company, with over $100 million in revenue, producing over $16 million in positive EBITDA. We're very much focused on the commercial aspects of the business. We're not an R
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
